{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Cordero-Garcia C"],"funding":["Ipsen (Spain)"],"pagination":["40"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11769552"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["17(1)"],"pubmed_abstract":["The study aimed to identify expert opinions and obtain recommendations on the management of post-stroke hemiplegic shoulder pain (HSP) and treatment with botulinum toxin A (BoNT-A). A multicenter Delphi study was conducted using an online survey designed by a committee of experts with at least 10 years of experience in post-stroke HSP management with BoNT-A in Spain. Forty-seven panelists (specialists with at least 5 years of experience in post-stroke HSP management with BoNT-A) rated their level of agreement in two rounds based on acceptance by ≥66.7% of them. In round 1, 245 statements on three dimensions were evaluated (diagnosis, treatment, and follow-up of the HSP patients treated with BoNT-A). A total of 159 statements (70.9%) were finally accepted after round 2. Experts recommended "],"journal":["Toxins"],"pubmed_title":["Delphi Consensus on the Management of Spanish Patients with Post-Stroke Hemiplegic Shoulder Pain Treated with Botulinum Toxin A: Result Study."],"pmcid":["PMC11769552"],"funding_grant_id":["NA"],"pubmed_authors":["Herrera A","Cordero-Garcia C","de Torres I","Formigo-Couceiro J","Romero-Torres MD","Mena-Rodriguez A","Guirao L","Otero-Villaverde S","Santa C"],"additional_accession":[]},"is_claimable":false,"name":"Delphi Consensus on the Management of Spanish Patients with Post-Stroke Hemiplegic Shoulder Pain Treated with Botulinum Toxin A: Result Study.","description":"The study aimed to identify expert opinions and obtain recommendations on the management of post-stroke hemiplegic shoulder pain (HSP) and treatment with botulinum toxin A (BoNT-A). A multicenter Delphi study was conducted using an online survey designed by a committee of experts with at least 10 years of experience in post-stroke HSP management with BoNT-A in Spain. Forty-seven panelists (specialists with at least 5 years of experience in post-stroke HSP management with BoNT-A) rated their level of agreement in two rounds based on acceptance by ≥66.7% of them. In round 1, 245 statements on three dimensions were evaluated (diagnosis, treatment, and follow-up of the HSP patients treated with BoNT-A). A total of 159 statements (70.9%) were finally accepted after round 2. Experts recommended ","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Jan","modification":"2025-04-22T05:23:05.355Z","creation":"2025-04-05T21:19:00.899Z"},"accession":"S-EPMC11769552","cross_references":{"pubmed":["39852993"],"doi":["10.3390/toxins17010040"]}}